Renishaw Diagnostics Appoints New Head of Marketing
Molecular diagnostics business Renishaw Diagnostics Ltd, has announced the appointment of Jim Greaves as Head of Marketing.
Read MoreSearch Results for: liver disease
Scholar Calls for Consistent Regulation of Direct-to-Consumer Genetic Tests
An opinion piece by a legal scholar from the Johns Hopkins Berman Institute of Bioethics in this weeks issue of Nature calls for the FDA to regulate all health-related genetic tests.
Read More
Oncology Testing: Becoming More Effective, Specific, and Predictive
Advances in genomics and biomarker identification facilitate more accurate diagnoses for cancer patients.
Read MoreNew Study Demonstrates Clinical Validity of Lung Cancer Test EarlyCDT-Lung
Oncimmune (USA) LLC, provider of EarlyCDT-Lung, announces the publication of a study that demonstrates the clinical validity of the test.
Read MoreBD Diagnostics Receives Moderate Complexity Status for the BD MAX GBS Assay
BD Diagnostics announced that it has received “Moderate Complexity” status from the FDA, under the Clinical Laboratory Improvement Amendments (CLIA), for the BD MAX GBS Assay for Group B Streptococcus(GBS).
Read More